Semaglutide Weight Loss
- All
- News
- Videos
- Web Stories
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Weight-Loss Breakthrough: Drug Cuts Heart Risk Even If You Don't Shed Kilos
A large-scale study shows semaglutide reduces heart risks regardless of weight loss, suggesting the drug benefits cardiovascular health in more ways than previously thought. The findings highlight waist size as a stronger indicator of heart improveme
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Ozempic May Reduce Bone Density; Know Other Possible Side Effects
Ozempic contains an ingredient called semaglutide which is prescribed primarily for managing type-2 diabetes.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
Weight-Loss Breakthrough: Drug Cuts Heart Risk Even If You Don't Shed Kilos
A large-scale study shows semaglutide reduces heart risks regardless of weight loss, suggesting the drug benefits cardiovascular health in more ways than previously thought. The findings highlight waist size as a stronger indicator of heart improveme
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Ozempic May Reduce Bone Density; Know Other Possible Side Effects
Ozempic contains an ingredient called semaglutide which is prescribed primarily for managing type-2 diabetes.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
